Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYBeyondSpring Presents Lead Asset’s Mechanism Data for Prevention of Chemotherapy-Induced NeutropeniaPREV STORYBasilea licenses late-stage oncology drug candidate derazantinib from ArQule